483
Fermatex Vascular TechnologiesFDA 483 - Fermatex Vascular Technologies - June 24, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Fermatex Vascular Technologies in Wall Township, NJ, revealed significant deficiencies in manufacturing controls, environmental monitoring, and corrective and preventive action procedures. The firm failed to record critical manufacturing equipment settings in device history records and lacked adequate environmental monitoring for its cleanroom. Additionally, procedures for analyzing quality data for non-conforming products were not established.
- Person
Open in Dashboard
ID · 7c209278-0862-4ba8-9d53-eaacb655fed3